TR200909792A2 - Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu - Google Patents

Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu

Info

Publication number
TR200909792A2
TR200909792A2 TR2009/09792A TR200909792A TR200909792A2 TR 200909792 A2 TR200909792 A2 TR 200909792A2 TR 2009/09792 A TR2009/09792 A TR 2009/09792A TR 200909792 A TR200909792 A TR 200909792A TR 200909792 A2 TR200909792 A2 TR 200909792A2
Authority
TR
Turkey
Prior art keywords
combination
corticosteroid
dry powder
acid derivative
containing tiotropium
Prior art date
Application number
TR2009/09792A
Other languages
English (en)
Inventor
B�Lg�� Mahmut
Original Assignee
B�Lg�� Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Lg�� Mahmut filed Critical B�Lg�� Mahmut
Priority to TR2009/09792A priority Critical patent/TR200909792A2/tr
Priority to PCT/TR2010/000189 priority patent/WO2011078818A1/en
Priority to EP10773420.4A priority patent/EP2515848B1/en
Publication of TR200909792A2 publication Critical patent/TR200909792A2/tr
Priority to US13/531,972 priority patent/US8834931B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, solunum yolları rahatsızlıklarında kullanılmak üzere, tiotropium aktif maddesinin bir kortikosteroid ve etkili miktarlardaki kromolin türevi bir madde ile birlikte formüle edildiği inhalasyon yoluyla kullanılacak bir ilaç bileşimine dairdir.
TR2009/09792A 2009-12-25 2009-12-25 Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu TR200909792A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2009/09792A TR200909792A2 (tr) 2009-12-25 2009-12-25 Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
PCT/TR2010/000189 WO2011078818A1 (en) 2009-12-25 2010-09-22 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative
EP10773420.4A EP2515848B1 (en) 2009-12-25 2010-09-22 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative
US13/531,972 US8834931B2 (en) 2009-12-25 2012-06-25 Dry powder formulation containing tiotropium for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/09792A TR200909792A2 (tr) 2009-12-25 2009-12-25 Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu

Publications (1)

Publication Number Publication Date
TR200909792A2 true TR200909792A2 (tr) 2011-07-21

Family

ID=43216416

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/09792A TR200909792A2 (tr) 2009-12-25 2009-12-25 Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu

Country Status (3)

Country Link
EP (1) EP2515848B1 (tr)
TR (1) TR200909792A2 (tr)
WO (1) WO2011078818A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
WO2011093809A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic Dry powder pharmaceutical composition comprising tiotropium and ciclesonide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CN1150890C (zh) 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
MXPA03003751A (es) * 2000-10-31 2004-10-15 Boehringer Ingelheim Pharma Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y corticoesteroides.
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
CL2008000500A1 (es) * 2007-02-19 2008-09-05 Cipla Ltd Combinacion farmaceutica que comprende una combinacion de dos o mas broncodilatadores o una combinacion de al menos un broncodilatador y al menos un corticosteroide; uso para tratar o prevenir una enfermedad respiratoria; e inhalador que comprende di

Also Published As

Publication number Publication date
EP2515848B1 (en) 2014-11-12
EP2515848A1 (en) 2012-10-31
WO2011078818A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
UA112296C2 (uk) Сухий порошковий препарат, який містить інгібітор фосфодіестерази
TR201008226A2 (tr) Kapsül içeren bir inhalasyon cihazı.
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
PE20190406A1 (es) Composiciones farmaceuticas que comprenden bromuro de aclidinio
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
BR112015027017A2 (pt) composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
TR201002877A2 (tr) Blister ambalaj içeren inhalasyon cihazı
TR200909792A2 (tr) Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
TR201205852A2 (tr) Geliştirilmiş yeni kuru toz formülasyonu.
MX386593B (es) Composicion que comprende un verprosido como ingrediente activo para prevenir o tratar una enfermedad pulmonar obstructiva cronica y su uso
TR200909790A2 (tr) Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
TR201007250A2 (tr) Selobioz içeren formülasyon.
TR200909793A2 (tr) Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
TR200909789A2 (tr) Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
TR200907237A2 (tr) Tiotropyum kuru toz kombinasyonu
TR200907914A2 (tr) Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
TR201105367A2 (tr) Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
TR200803525A2 (tr) Toz ilaç soluma cihazı.
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
TR201007251A2 (tr) Kalsiyum kanal blokörü formülasyonu.
TR201000621A2 (tr) Tiotropium ve budesonid içeren kuru toz formundaki farmasötik kompozisyon